PNC Financial Services Group Inc. Purchases New Position in Septerna, Inc. (NASDAQ:SEPN)

PNC Financial Services Group Inc. acquired a new position in Septerna, Inc. (NASDAQ:SEPN) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,680 shares of the company’s stock, valued at approximately $61,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. New York State Common Retirement Fund bought a new stake in shares of Septerna in the 4th quarter worth $32,000. SG Americas Securities LLC bought a new stake in Septerna in the 4th quarter worth about $185,000. M&T Bank Corp purchased a new position in Septerna in the 4th quarter worth about $376,000. Rhumbline Advisers bought a new position in Septerna during the 4th quarter valued at about $458,000. Finally, Lindbrook Capital LLC purchased a new stake in shares of Septerna during the 4th quarter valued at about $481,000.

Insider Activity

In related news, CFO Gil M. Labrucherie acquired 5,000 shares of the stock in a transaction dated Friday, February 21st. The shares were purchased at an average cost of $5.85 per share, with a total value of $29,250.00. Following the transaction, the chief financial officer now directly owns 30,000 shares in the company, valued at approximately $175,500. This represents a 20.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Alan Ezekowitz bought 41,355 shares of Septerna stock in a transaction that occurred on Thursday, March 6th. The stock was purchased at an average cost of $6.00 per share, with a total value of $248,130.00. Following the completion of the acquisition, the director now directly owns 104,101 shares in the company, valued at $624,606. This represents a 65.91 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 74,346 shares of company stock valued at $439,670 in the last 90 days.

Septerna Price Performance

Shares of NASDAQ SEPN opened at $6.14 on Thursday. Septerna, Inc. has a 12-month low of $4.17 and a 12-month high of $28.99. The firm’s 50 day simple moving average is $10.39.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SEPN. Wells Fargo & Company cut shares of Septerna from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $43.00 to $14.00 in a report on Tuesday, February 18th. Cantor Fitzgerald reissued an “overweight” rating and set a $50.00 price target on shares of Septerna in a report on Tuesday, February 11th.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.